Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia: A Comprehensive Review of Recent Literature

Cited by (1,000)

Items 501–600 of 1,000

1. Attitudes and subjective reasons of medication compliance and noncompliance among outpatients with schizophrenia in India
   2009 · The Internet Journal of Epidemiology
2. Detecting non-adherence by urine analysis in patients with uncontrolled hypertension: rates, reasons and reactions
   Mark Pucci, Una Martin · 2016 · Journal of Human Hypertension
3. Tolerability of effective high doses of paliperidone palmitate in patients with severe resistant schizophrenia
   J. J. Fernández-Miranda, S. Díaz-Fernández · 2017 · International Clinical Psychopharmacology
4. A psychological flexibility model of medication adherence in psychotic-spectrum disorders
   Ethan Moitra, Brandon A. Gaudiano · 2016 · Journal of Contextual Behavioral Science
5. Indications for and use of long-acting injectable antipsychotics
   Taishiro Kishimoto, Sohag N. Sanghani, Mark J. Russ, Akeem Nassor Marsh, Joshua Morris, Suparna Basu, Majnu John, John Michael Kane · 2017 · International Clinical Psychopharmacology
6. Bibliometric analysis of global publications in medication adherence (1900–2017)
   W. Sweileh, Samah W. Al-Jabi, S. Zyoud, Nasr Y. Shraim, F. Anayah, A. Sawalha, Adham S. AbuTaha · 2018 · International Journal of Pharmacy Practice
7. How do people talk decades later about their crisis that we call psychosis? A qualitative study of the personal meaning-making process
   Tomi Bergström, Jaakko Seikkula, Juha Matti Holma, Pirjo H. Mäki, Päivi Köngäs‐Saviaro, Birgitta Alakare · 2019 · Psychosis
8. Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia☆
   Mamta Sapra, Ipsit Vihang Vahia, Pia Reyes, PAUL MICHAEL RAMIREZ, Carl I. Cohen · 2008 · Schizophrenia Research
9. Leverage, the Treatment Relationship, and Treatment Participation
   McNiel, Dale E., Gormley, Barbara, Binder, Renée L. · 2013 · Psychiatric Services
10. Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia
    Antonio Ciudad, Luis San, Miquel Bernardo, José Manuel Olivares, Pepa Polavieja, Amparo Valladares, Inmaculada Gilaberte · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
11. Costs of treating patients with schizophrenia who have illness-related crisis events
    Baojin Zhu, Haya Ascher‐Svanum, Douglas E. Faries, Xiaomei Peng, David S. Salkever, Eric P. Slade · 2008 · BMC Psychiatry
12. Addressing non‐adherence to antipsychotic medication: a harm‐reduction approach
    M. A. ALDRIDGE · 2011 · Journal of Psychiatric and Mental Health Nursing
13. Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking
    Benedicto Crespo‐Facorro, Miquel Bernardo, Josep M. Argimón, Manuel Arrojo, María Fe Bravo‐Ortiz, Ana Cabrera-Cifuentes, Julián Carretero Román, Manuel Franco, María Paz García‐Portilla, Josep Maria Haro et al. · 2016 · Revista de Psiquiatría y Salud Mental
14. Telephone-delivered psychosocial interventions targeting key health priorities in adults with a psychotic disorder: systematic review
    Amanda Baker, Alyna Turner, Alison Kate Beck, Katherine Berry, Gillian Haddock, Peter J. Kelly, Sandra Bucci · 2018 · Psychological Medicine
15. Benefits and harms of providing biological causal models in the treatment of psychosis – An experimental study
    Eva Lüllmann, Sven Berendes, Winfried Rief, Tania M. Lincoln · 2011 · Journal of Behavior Therapy and Experimental Psychiatry
16. Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders
    Nils Eiel Steen, Monica Aas, Carmen Simonsen, Ingrid Dieset, Martin Tesli, Mari Nerhus, Erlend Strand Gardsjord, Ragni Helene Mørch, Ingrid Agartz, Ingrid S. Melle et al. · 2016 · The World Journal of Biological Psychiatry
17. Medication-related factors of non adherence among patients with schizophrenia and bipolar disorder: Outcome of a cross-sectional survey in Maiduguri, North-eastern Nigeria
    Ibrahim, A W, Pindar, S K, Yerima, M M, Rabbebe, I B, Shehu, S et al. · 2015 · Journal of Neuroscience and Behavioral Health
18. An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorder
    Justin Faden, Camila Ramirez, Vanessa Martinez, Leslie Citrome · 2024 · Expert Review of Neurotherapeutics
19. Differences in Adherence to Antihypertensive Medication Regimens According to Psychiatric Diagnosis: Results of a Korean Population-Based Study
    Ha Kyoung Kim, Jong Hyock Park, Jae‐Hyun Park, Jong Heun Kim · 2009 · Psychosomatic Medicine
20. Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence
    Kelin Kelin, Haya Ascher‐Svanum, Tim J R Lambert, Alan J. M. Brnabic, Richard Newton, Wenyu Ye, Escamilla, Kuang‐Peng Chen, Liana Don, William S. Montgomery et al. · 2011 · Patient Preference and Adherence
21. Enhancing adherence, subjective well-being and quality of life in patients with schizophrenia: which role for long-acting risperidone?
    Cinzia Niolu, Emanuela Bianciardi, Giorgio Di Lorenzo, Claudia Marchetta, Ylenia Barone, Nicoletta Sterbini, Michele Ribolsi, Giorgio Reggiardo, Alberto Siracusano · 2015 · Therapeutic Advances in Psychopharmacology
22. Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation
    Matthew C. Dickson, Michael M. Nguyen, Charmi A. Patel, Shannon C. Grabich, Carmela J. Benson, Terry Cothran, Grant H. Skrepnek · 2022 · Advances in Therapy
23. The Relationship Between Level of Education, Cognitive Function and Medication Adherence in Patients with Schizophrenia
    Xiaodan Zhu, Min Wen, Ying Hé, Jing Feng, Xuebing Xu, Juan Liu · 2023 · Neuropsychiatric Disease and Treatment
24. Predictors of Medication Non-adherence in Bulgarian Outpatients with Schizophrenia
    Iglika Vassileva, Vihra Milanova, Turan Asan · 2014 · Community Mental Health Journal
25. The management of schizophrenia: focus on extended-release quetiapine fumarate
    Joseph Peuskens · 2011 · Neuropsychiatric Disease and Treatment
26. Effect of medication-related factors on adherence in people with schizophrenia: A European multi-centre study
    Johanna Meier, Thomas M Becker, Anita K. Patel, Debbie Robson, Aart H. Schene, Martijn Kikkert, Corrado Barbui, Lorenzo Burti, Bernd Puschner · 2010 · Epidemiologia e Psichiatria Sociale
27. Health literacy and the Clozapine patient
    Susan Brosnan, Elizabeth Barron, Laura Jane Sahm · 2012 · Perspectives in Public Health
28. Prevalence and predictors of poor medication adherence among out-patients at a psychiatric hospital in Benin City, Nigeria
    Bawo Onesirosan James, Joyce Ohiole Omoaregba · 2010 · International Journal of Psychiatry in Clinical Practice
29. Mortality, disability, psychiatric treatment and medication in first-onset schizophrenia in Finland : the register linkage study
    Marjo Kiviniemi · 2014
30. Effect of a Telephone Intervention Upon Self-Reported Medication Adherence and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs)
    Lora Humphrey Beebe, Kathlene Smith, Chad Phillips · 2016 · Issues in Mental Health Nursing
31. Relating to the Speaker behind the Voice: What Is Changing?
    Felicity Deamer, Mark Hayward · 2018 · Frontiers in Psychology
32. Medication adherence in first‐episode psychosis patients in Singapore
    Chunzhen Tan, Edimansyah Abdin, Wilfred Liang, Lye Yin Poon, Ngar Yee Poon, Swapna Kamal Verma · 2018 · Early Intervention in Psychiatry
33. Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs – A study based on blood sample analyses from 24,239 patients
    Robert L. Smith, Marit Tveito, Lennart Kyllesø, Marin M. Jukić, Magnus Ingelman‐Sundberg, Ole A. Andreassen, Espen Molden · 2020 · European Neuropsychopharmacology
34. Adherence with Outpatient Appointments and Medication: A Two-Year Prospective Study of Patients with Schizophrenia
    Adem Balıkçı, Murat Erdem, Serkan Zincir, Abdullah Bolu, Selma Bozkurt Zincir, Sarper Ercan, Özcan Uzun · 2013 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
35. Prevalence and predictors of medication non-adherence among Chinese patients with first-episode psychosis
    Christy Lai Ming Hui, Venessa Wing-Yan Poon, Vivian Shuk-Kuen Kwok, Wing Chung Chang, Sherry Kit Wa Chan, Edwin Ho Ming Lee, Eric Yu Hai Chen · 2015 · Psychiatry Research
36. A Comparison of Various Methods of Measuring Antidepressant Medication Adherence Among Children and Adolescents with Major Depressive Disorder in a 12-Week Open Trial of Fluoxetine
    Paul A. Nakonezny, Carroll W. Hughes, Taryn L. Mayes, Kathryn H. Sternweis-Yang, Betsy D. Kennard, Matthew Byerly, Graham J. Emslie · 2010 · Journal of Child and Adolescent Psychopharmacology
37. Long-Acting Injectables and Risk for Rehospitalization Among Patients With Schizophrenia in the Home Care Program in Taiwan
    Po‐Chung Ju, Frank Huang‐Chih Chou, Te-Jen Lai, Po-Ya Chuang, Yung-Jung Lin, Ching-Wen Wendy Yang, Chao‐Hsiun Tang · 2013 · Journal of Clinical Psychopharmacology
38. Antipsychotic treatment dosing profile in patients with schizophrenia evaluated with electronic monitoring (MEMS®)
    Francisco J. Acosta, Yolanda Ramallo‐Fariña, Esperanza Bosch, Teresa Mayans, Carlos J. Rodríguez, Ana Caravaca · 2013 · Schizophrenia Research
39. Alcohol use and adherence to prescribed therapy among under-served Latino and African-American patients using emergency department services.
    Shahrzad Bazargan‐Hejazi, Mohsen Bazargan, Eugene A. Hardin, Eric G. Bing · 2005 · PubMed
40. Compilation of Quantitative Overviews of Studies of Adherence
    Alan Morrison, Albert I. Wertheimer · 2004 · Drug Information Journal
41. The Pharmacokinetics of Second-Generation Long-Acting Injectable Antipsychotics: Limitations of Monograph Values
    Lee, Lik Hang N., Choi, Charles, Collier, Abby C., Barr, Alasdair M., Honer, William G., Procyshyn, Ric M. · 2015 · CNS Drugs
42. Adherence therapy following acute exacerbation of schizophrenia: A randomised controlled trial in Thailand
    Suparpit von Bormann, Debbie Robson, Richard John Gray · 2014 · International Journal of Social Psychiatry
43. Genetic association analysis of N‐methyl‐ d ‐aspartate receptor subunit geneGRIN2Band clinical response to clozapine
    Danielle L. Taylor, Arun Kumar Tiwari, Jeffrey Alan Lieberman, Steven G. Potkin, Herbert Y. Meltzer, Jo Knight, Gary J. Remington, Daniel J. Müller, James L. Kennedy · 2016 · Human Psychopharmacology Clinical and Experimental
44. Attitude and perceptions of patients towards long acting depot injections (LAIs)
    Sandeep Grover, Swapnajeet Sahoo, Subodh BN, Nidhi Malhotra, Devakshi Dua, Ajit Avasthi · 2019 · Asian Journal of Psychiatry
45. Risk of subsequent relapses and corresponding healthcare costs among recently-relapsed Medicaid patients with schizophrenia: a real-world retrospective cohort study
    Charmi A. Patel, Bruno Émond, Laura Morrison, Marie‐Hélène Lafeuille, Patrick Lefèbvre, Dee Lin, Edward Kim, Kruti Joshi · 2021 · Current Medical Research and Opinion
46. Schizophrenia through the carers' eyes: results of a European cross‐sectional survey
    Alessandro Svettini, B. Johnson, C. Magro, J R SAUNDERS, K. Jones, S. Silk, L. Hargarter, Andreas Schreiner · 2015 · Journal of Psychiatric and Mental Health Nursing
47. Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
    Tatiana Dilla, Jörgen Möller, Paul O’Donohoe, María Álvarez, José Antonio Sacristán, Michael Happich, Antje Tockhorn‐Heidenreich · 2014 · BMC Psychiatry
48. The knowledge and attitudes of psychiatrists towards antipsychotic long-acting injections in Nigeria
    Bawo Onesirosan James, Joyce Ohiole Omoaregba, Kingsley Mayowa Okonoda, Edebi U. Otefe, Maxine X. Patel · 2012 · Therapeutic Advances in Psychopharmacology
49. The Effect of an Educating versus Normalizing Approach on Treatment Motivation in Patients Presenting with Delusions: An Experimental Investigation with Analogue Patients
    Eva Lüllmann, Tania M. Lincoln · 2013 · Schizophrenia Research and Treatment
50. Prevalence and factors associated with medication compliance in Indian patients suffering from mental disorders
    Sangeeta Sharma, Naveen Kumar, Saswati Chakraborti, Sampa Sinha, Sushma Kumari, Jahanara M. Gajendragad · 2011 · Tropical Doctor
51. Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans
    Bruno Émond, Antoine C. El Khoury, Charmi A. Patel, Dominic Pilon, Laura Morrison, Maryia Zhdanava, Patrick Lefèbvre, Neeta Tandon, Kruti Joshi · 2018 · Current Medical Research and Opinion
52. Effect of adding individualized occupational therapy to standard care on rehospitalization of patients with schizophrenia: A 2‐year prospective cohort study
    Takeshi Shimada, Manami Ohori, Yusuke Inagaki, Yuko Shimooka, Ikuyo Ishihara, Naoya Sugimura, Sachie Tanaka, Masayoshi Kobayashi · 2019 · Psychiatry and Clinical Neurosciences
53. Why Do Patients with Schizophrenia Who Have Poor Insight Still Take Antipsychotics? Memory Deficits as Moderators Between Adherence Belief and Behavior
    Anton B. P. Staring, Mark van der Gaag, Hugo Joseph Duivenvoorden, Peter J. Weiden, Cornelis L. Mulder · 2011 · Journal of Psychiatric Practice
54. Prisoners' experiences of antipsychotic medication: influences on adherence
    Alice Mills, Judith Lathlean, Daniel Thomas Bressington, Andrew Forrester, Wilhelm Van Veenhuyzen, Richard John Gray · 2010 · Journal of Forensic Psychiatry and Psychology
55. An Outbreak of Tuberculosis Among Adults With Mental Illness
    Joseph S. Cavanaugh, Krista M. Powell, Ozzie J. Renwick, Kevin L. Davis, Aaron L. Hilliard, Cynthia Benjamin, Kiren Mitruka · 2012 · American Journal of Psychiatry
56. A Review of Brief Medication-Adherence Instruments Used in Patients with Schizophrenia and Bipolar Disorder
    Brian Pomykacz, Melissa Mao, Roger D. Roger, Christian J. Teter · 2007 · Harvard Review of Psychiatry
57. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research
    Olivier Blanc, Georges Brousse, Alexandre Méary, Marion Leboyer, Pierre‐Michel Llorca · 2009 · Fundamental and Clinical Pharmacology
58. Optimization of formulation variables for the development of long acting microsphere based depot injection of olanzapine
    Tushar Nahata, T. R. Saini · 2008 · Journal of Microencapsulation
59. Non-adherence level of pharmacotherapy and its predictors among mental disorders in a resource-limited life trajectories: a systematic review and meta-analysis
    Woretaw Sisay Zewdu, Samuel Berihun Dagnew, Getachew Yitayew Tarekegn, Taklo Simeneh Yazie, Meswait Asrat Ayicheh, Fisseha Nigussie Dagnew, Tilaye Arega Moges · 2025 · BMC Psychiatry
60. Systematic Literature Review of Text Messaging Interventions to Promote Medication Adherence Among People With Serious Mental Illness
    Emily Simon, Alyssa M Edwards, Martha Sajatovic, Nisha Jain, Jessica L. Montoya, Jennifer B. Levin · 2022 · Psychiatric Services
61. Decreased insight, but not self-stigma or belief about medicine, is associated with greater severity of delusions in a sample of long-stay patients with schizophrenia: a cross-sectional study
    Christina Beainy, Chadia Haddad, Feten Fekih‐Romdhane, Souheil R. Hallit, Georges Haddad · 2023 · BMC Psychiatry
62. How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients
    Guillaume B. Fond, Bruno Falissard, Philippe Nuss, Cédric Collin, Stéphanie Duret, Marc Rabbani, Isabelle De Chefdebien, Isabelle Tonelli, Pierre‐Michel Llorca, Laurent Boyer · 2023 · Molecular Psychiatry
63. Smartphone Applications for Educating and Helping Non-motivating Patients Adhere to Medication That Treats Mental Health Conditions: Aims and Functioning
    Angelos P. Kassianos, Giοrgos Georgiou, Electra P. Papaconstantinou, Angeliki Detzortzi, Robert Horne · 2017 · Frontiers in Psychology
64. Causal beliefs in people experiencing psychosis: The relationship to treatment accessed and the perceived helpfulness of treatment
    Lucy Carter, John Read, Melissa Pyle, Heather Law, Richard Emsley, Anthony P. Morrison · 2017 · Psychology and Psychotherapy Theory Research and Practice
65. Exploring predictors of medication adherence among inpatients with schizophrenia in Singapore's mental health settings: A non-experimental study
    Xiang Cong Tham, Huiting Xie, Cecilia Mui Lee Chng, Ming-Yi Seah, Violeta López, Piyanee Klainin‐Yobas · 2018 · Archives of Psychiatric Nursing
66. Relationship Between Illness Representations, Psychosocial Adjustment, and Treatment Outcomes in Mental Disorders: A Mini Review
    Priscillia Averous, Élodie Charbonnier, Lionel Dany · 2020 · Frontiers in Psychology
67. Opinion Piece: The case for establishing a minimal medication alternative for psychosis and schizophrenia
    Ruth E Cooper, J Mason, Tim Calton, John M. Richardson, Joanna Moncrieff · 2021 · Psychosis
68. Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study
    Leslie Citrome, Emily D. Belcher, Sylvie Stacy, Mark Suett, Marko Mychaskiw, Gregory D Salinas · 2022 · Patient Preference and Adherence
69. Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration
    Xinhua Steve Ren, Concetta Crivera, Mirko V. Sikirica, Riad D Dirani, Shirley X. Qian, Lewis E. Kazis · 2010 · Journal of Clinical Pharmacy and Therapeutics
70. Attitudes toward medication in inpatients with schizophrenia: A cluster analytic approach
    Giovanni Santone, Paola Rucci, Marco Lazzarotto Muratori, Andrea Monaci, Cristina Ciarafoni, Gabriele Borsetti · 2008 · Psychiatry Research
71. Factors related to antipsychotic oversupply among central Texas Veterans
    Min Suk Yang, Jamie C. Barner, Jason Worchel · 2007 · Clinical Therapeutics
72. Do Patients With Schizophrenia Distinguish Between Attitudes Toward Antipsychotic Medication and Pharmacotherapy in General?
    Eva‐Marina Beck, Roman Vögelin, Markus Antonius Wirtz, Marialuisa Cavelti, Sara Kvrgic, Roland Vauth · 2011 · The Journal of Nervous and Mental Disease
73. Time to Discontinuation of Second-Generation Antipsychotics Versus Haloperidol and Sulpiride in People With Schizophrenia
    Hung‐Yu Chan, Yi‐Ju Pan, Jiahn‐Jyh Chen, Chiung-Hsu Chen · 2016 · Journal of Clinical Psychopharmacology
74. Tools for measuring clinical effectiveness
    Dieter Naber, Antonio Vita · 2004 · European Neuropsychopharmacology
75. Communication about adherence to long-term antipsychotic prescribing: an observational study of psychiatric practice
    Alan Quirk, Rob Chaplin, Sarah Hamilton, Paul T. Lelliott, Clive F. Seale · 2012 · Social Psychiatry and Psychiatric Epidemiology
76. Effect of initial ziprasidone dose on treatment persistence in schizophrenia
    C. Daniel Mullins, Fadia Tohme Shaya, JULIE MAGNO ZITO, Nour Ali Obeidat, John Naradzay, David James Harrison · 2006 · Schizophrenia Research
77. From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials
    Jonathan M. Meyer, Ken Kramer, Scott C. Vuocolo, Inder Kaul, Andrew C Miller · 2025 · The International Journal of Neuropsychopharmacology
78. The impact of trust in healthcare and medication, and beliefs about medication on medication adherence in a Dutch medication-using population
    Roland te Paske, Marcia Vervloet, Annemiek J. Linn, Anne E. M. Brabers, Job F. M. van Boven, Liset van Dijk · 2023 · Journal of Psychosomatic Research
79. Olanzapine pamoate for the treatment of schizophrenia
    Dieter Naber · 2011 · Expert Opinion on Pharmacotherapy
80. Psikiyatri Hastalarının Tedaviye Uyumu
    Mehmet Emin Demirkol, Lut Tamam, Yunus Emre Evlice, Mahmut Onur Karaytuğ · 2015 · Cukurova Medical Journal (Çukurova Üniversitesi Tıp Fakültesi Dergisi)
81. Correlates of Negative Attitudes towards Medication in People with Schizophrenia
    Lucie Kondrátová, Daniel König, Karolína Mladá, Petr Winkler · 2018 · Psychiatric Quarterly
82. Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database
    Masakazu Hatano, Hiroyuki Kamei, Akane Shimato, Shigeki Yamada, Nakao Iwata · 2020 · Psychiatry Research
83. Pharmaceutical care and medication adherence in management of psychosis in a Nigerian tertiary hospital
    Kakjing Dadul Falang, RaymondA Barde, NS Jimam, Dauda Audi Dangiwa, Hafsat Olufunke Jimoh, Jonathan Danladi · 2013 · Journal of Research in Pharmacy Practice
84. Offering Financial Incentives to Increase Adherence to Antipsychotic Medication
    Elizabeth Highton‐Williamson, Kirsten Barnicot, Tarrannum Kareem, Stefan Priebe · 2015 · Journal of Clinical Psychopharmacology
85. Dynamic Psychopharmacology and Treatment Adherence
    César A. Alfonso · 2009 · Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
86. Psychosocial and psychological interventions in early psychosis: essential elements for recovery
    Eoin J. Killackey · 2009 · Early Intervention in Psychiatry
87. Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers
    Sherry Kit Wa Chan, Men Heng Marian Wong, Christy Lai Ming Hui, Edwin Ho Ming Lee, Wing Chung Chang, Eric Yu Hai Chen · 2014 · Social Psychiatry and Psychiatric Epidemiology
88. Beliefs about medication, medication adherence and seizure control among adult epilepsy patients in Kimberley, South Africa
    Chika K. Egenasi, Wilhelm Johannes Steinberg, Jacques Raubenheimer · 2015 · South African Family Practice
89. Nurses’ perceptions of medication adherence in schizophrenia: results of the ADHES cross-sectional questionnaire survey
    Robin Alexander Emsley, Köksal Alptekın, Jean‐Michel Azorin, Fernando Cañas, Vincent Dubois, Philip A. P. M. Gorwood, Peter Michael Haddad, Dieter Naber, José Manuel Olivares, Georgios Papageorgiou et al. · 2015 · Therapeutic Advances in Psychopharmacology
90. Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study
    Esther Jung, Martin Wiesjahn, Hanna Wendt, Thomas A. Bock, Winfried Rief, Tania M. Lincoln · 2016 · Psychological Medicine
91. Longitudinal trajectory of clinical insight and covariation with cortical thickness in first-episode psychosis
    Lisa Buchy, Carolina Makowski, ASHOK K. MALLA, Ridha Joober, Martín Lepage · 2016 · Journal of Psychiatric Research
92. Prognostic indicators for early discontinuation of risperidone long-acting injection
    Maxine X. Patel, Corina Young, Chiara Samele, David M. Taylor, Anthony S. David · 2004 · International Clinical Psychopharmacology
93. Negotiating styles adopted by consultant psychiatrists when prescribing antipsychotics
    Robert Chaplin, Paul T. Lelliott, Alan Quirk, Clive F. Seale · 2006 · Advances in Psychiatric Treatment
94. Effects of antipsychotic drugs on insight in schizophrenia
    Bianchini, Oriana, Porcelli, Stefano, Nespeca, Claudia, Cannavò, Dario, Trappoli, Angela, Aguglia, Eugenio, De Ronchi, Diana, Serretti, Alessandro · 2014 · Psychiatry Research
95. Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia
    Maria Jesús Arranz, Janet C. Munro · 2011 · Expert Review of Clinical Pharmacology
96. An analysis of the relationship between social support levels and treatment compliance of individuals diagnosed with schizophrenia
    Özlem Şahi̇n Altun, Sibel Asi̇ Karakaş, Zeynep Öztürk, Hatice Polat · 2021 · Perspectives In Psychiatric Care
97. Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey
    Alexander Keenan, Dee Lin, Jason Shepherd, Hollie M. L. Bailey, Carmela J. Benson, Sophie Meakin · 2022 · BMC Psychiatry
98. Compliance with Oral Nutritional Supplementation among Gastric Cancer Patients at Nutritional Risk: A Cross-Sectional Study
    Xiaohan Jiang, Xijie Chen, Shi Chen, Jia-min Chen, Xiuhong Yuan, Yijia Lin, Yonghe Chen, Yue-e Wen, Junsheng Peng · 2022 · Nutrition and Cancer
99. Antipsychotic Treatment Discontinuation Among Individuals With Schizophrenia and Co-occurring Substance Use
    David A. Smelson, Sandra L. Tunis, Allen W. Nyhuis, Douglas E. Faries, Bruce J. Kinon, Haya Ascher‐Svanum · 2006 · Journal of Clinical Psychopharmacology
100. Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study
     Adam Jonathan Savitz, Haiyan Xu, Srihari Gopal, Isaac F. Nuamah, Paulien G. M. Ravenstijn, David Hough, Maju Mathews, Yu Feng, Lu Yu, Masayoshi Takahashi et al. · 2017 · Neuropsychiatric Disease and Treatment